NRC Health Excess Tax Benefit from Share-based Compensation, Operating Activities
NRC Health (NRC) reported Excess Tax Benefit from Share-based Compensation, Operating Activities of -$38.00 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-05.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2018-03-14
- NRC Health excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-06-30 was $0.00.
- NRC Health excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-03-31 was -$38.00K.
- NRC Health excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-12-31 was -$11.00K.
- NRC Health excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-09-30 was $0.00.
- NRC Health excess tax benefit from share-based compensation, operating activities for fiscal 2015 was -$25.00K.
- NRC Health excess tax benefit from share-based compensation, operating activities for fiscal 2014 was -$93.00K.
- NRC Health excess tax benefit from share-based compensation, operating activities for fiscal 2013 was -$84.00K, a 113.98% decline from fiscal 2012.
- NRC Health excess tax benefit from share-based compensation, operating activities for fiscal 2012 was $601.00K, a 810.61% increase from fiscal 2011.
| Period end | Excess Tax Benefit from Share-based Compensation, Operating Activities 3 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 6 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 9 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$38.00K 10-Q · filed 2016-08-05 | -$49.00K derived: sum of 3 quarters · filed 2018-03-14 | -$49.00K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-03-31 | -$38.00K 10-Q · filed 2016-05-06 | -$49.00K derived: sum of 2 quarters · filed 2018-03-14 | -$49.00K derived: sum of 3 quarters · filed 2018-03-14 | -$49.00K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2015-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$11.00K derived: sum of 2 quarters · filed 2018-03-14 | -$11.00K derived: sum of 3 quarters · filed 2018-03-14 | -$25.00K 10-K · filed 2018-03-14 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2016-08-05 | -$14.00K 10-Q · filed 2015-11-05 | -$34.00K derived: sum of 4 quarters · filed 2017-03-03 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$14.00K 10-Q · filed 2016-08-05 | -$34.00K derived: sum of 3 quarters · filed 2017-03-03 | -$34.00K derived: sum of 4 quarters · filed 2017-03-03 | |
| 2015-03-31 | -$14.00K 10-Q · filed 2016-05-06 | -$34.00K derived: sum of 2 quarters · filed 2017-03-03 | -$34.00K derived: sum of 3 quarters · filed 2017-03-03 | -$35.00K derived: sum of 4 quarters · filed 2017-03-03 | |
| 2014-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$20.00K derived: sum of 2 quarters · filed 2017-03-03 | -$21.00K derived: sum of 3 quarters · filed 2017-03-03 | -$93.00K 10-K · filed 2017-03-03 | $93.00K 10-K · filed 2015-03-04 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$1.00K derived: sum of 2 quarters · filed 2015-11-05 | -$73.00K 10-Q · filed 2015-11-05 | -$101.00K derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$73.00K 10-Q · filed 2015-08-06 | -$101.00K derived: sum of 3 quarters · filed 2016-03-04 | -$101.00K derived: sum of 4 quarters · filed 2016-03-04 | |
| 2014-03-31 | -$72.00K 10-Q · filed 2015-05-08 | -$100.00K derived: sum of 2 quarters · filed 2016-03-04 | -$100.00K derived: sum of 3 quarters · filed 2016-03-04 | -$100.00K derived: sum of 4 quarters · filed 2016-03-04 | |
| 2013-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | -$28.00K derived: sum of 2 quarters · filed 2016-03-04 | -$28.00K derived: sum of 3 quarters · filed 2016-03-04 | -$84.00K 10-K · filed 2016-03-04 | $84.00K 10-K · filed 2014-03-04 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 derived: sum of 2 quarters · filed 2014-11-07 | -$56.00K 10-Q · filed 2014-11-07 | $918.00K derived: sum of 4 quarters · filed 2015-03-04 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | -$56.00K 10-Q · filed 2014-08-06 | $918.00K derived: sum of 3 quarters · filed 2015-03-04 | $818.00K derived: sum of 4 quarters · filed 2015-03-04 | |
| 2013-03-31 | -$56.00K 10-Q · filed 2014-05-08 | $918.00K derived: sum of 2 quarters · filed 2015-03-04 | $818.00K derived: sum of 3 quarters · filed 2015-03-04 | $758.00K derived: sum of 4 quarters · filed 2015-03-04 | |
| 2012-12-31 | $974.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04 | $874.00K derived: sum of 2 quarters · filed 2015-03-04 | $814.00K derived: sum of 3 quarters · filed 2015-03-04 | $601.00K 10-K · filed 2015-03-04 | |
| 2012-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$160.00K derived: sum of 2 quarters · filed 2013-11-07 | -$373.00K 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | -$60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$273.00K 10-Q · filed 2013-08-08 | |||
| 2012-03-31 | -$213.00K 10-Q · filed 2013-05-08 | ||||
| 2011-12-31 | $66.00K 10-K · filed 2014-03-04 | ||||
| 2010-12-31 | $33.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |